109 related articles for article (PubMed ID: 1686880)
1. Multiple effects of interferon on HIV-1 replication.
Pitha PM
J Interferon Res; 1991 Dec; 11(6):313-8. PubMed ID: 1686880
[No Abstract] [Full Text] [Related]
2. [Recombinant interferon-alpha suppression of Karelian fever virus replication in human blood cells].
Sokolova TM; Shuvalov AN
Vopr Virusol; 2012; 57(2):27-31. PubMed ID: 22834144
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of antiviral action of interferon.
Baglioni C; Nilsen TW
Interferon; 1983; 5():23-42. PubMed ID: 6202642
[No Abstract] [Full Text] [Related]
4. Contribution of MX dynamin, oligoadenylate synthetase, and protein kinase R to anti-paramyxovirus activity of type 1 interferons in vitro.
Leroy MP; Baise EA; Pire GA; Desmecht DJ
Am J Vet Res; 2007 Sep; 68(9):988-94. PubMed ID: 17764414
[TBL] [Abstract][Full Text] [Related]
5. Resistance of hepatitis delta virus replication to interferon-alpha treatment in transfected human cells.
Ilan Y; Klein A; Taylor J; Tur-Kaspa R
J Infect Dis; 1992 Nov; 166(5):1164-6. PubMed ID: 1328404
[TBL] [Abstract][Full Text] [Related]
6. Hormonal and immunological regulation of 2', 5'-oligoadenylate synthetase activity in human peripheral blood mononuclear cells.
Miele ME; Vesell ES; Ehmann WC; Lipton A; Harvey H; Kan NC
Clin Immunol Immunopathol; 1992 Nov; 65(2):183-92. PubMed ID: 1356675
[TBL] [Abstract][Full Text] [Related]
7. Type I interferons inhibit hepatitis B virus replication and induce hepatocellular gene expression in cultured liver cells.
Caselmann WH; Meyer M; Scholz S; Hofschneider PH; Koshy R
J Infect Dis; 1992 Nov; 166(5):966-71. PubMed ID: 1328410
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of recombinant interferon-alpha on hepatitis A virus replication in human liver cells.
Crance JM; Lévêque F; Chousterman S; Jouan A; Trépo C; Deloince R
Antiviral Res; 1995 Sep; 28(1):69-80. PubMed ID: 8585761
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha and interferon-gamma inhibit synergistically viral replication in hepatitis B virus-replicating cells.
Kawanishi Y; Hayashi N; Katayama K; Ueda K; Takehara T; Miyoshi E; Mita E; Kasahara A; Fusamoto H; Kamada T
J Med Virol; 1995 Nov; 47(3):272-7. PubMed ID: 8551280
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis delta virus replication in vitro is not affected by interferon-alpha or -gamma despite intact cellular responses to interferon and dsRNA.
McNair AN; Cheng D; Monjardino J; Thomas HC; Kerr IM
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1371-8. PubMed ID: 7911507
[TBL] [Abstract][Full Text] [Related]
11. Induction of interferon regulatory factors 2'-5' oligoadenylate synthetase, P68 kinase and RNase L in chronic myelogenous leukaemia cells and its relationship to clinical responsiveness.
Fischer T; Aman J; van der Kuip H; Rudolf G; Peschel C; Aulitzky WE; Huber C
Br J Haematol; 1996 Mar; 92(3):595-603. PubMed ID: 8616023
[TBL] [Abstract][Full Text] [Related]
12. Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle.
Shirazi Y; Pitha PM
J Virol; 1992 Mar; 66(3):1321-8. PubMed ID: 1738192
[TBL] [Abstract][Full Text] [Related]
13. Anti-hepatitis B virus activity and mechanisms of recombinant human serum albumin-interferon-alpha-2b fusion protein in vitro and in vivo.
Bingfa X; Qinglin F; Hui H; Canjun W; Wei W; Lihua S
Pharmacology; 2009; 83(6):323-32. PubMed ID: 19407486
[TBL] [Abstract][Full Text] [Related]
14. Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells.
Shirazi Y; Pitha PM
Virology; 1993 Mar; 193(1):303-12. PubMed ID: 8438572
[TBL] [Abstract][Full Text] [Related]
15. Induction of anti-viral activity and specific enzymes in cell-lines derived from interferon-resistant, thymidine kinase deficient mouse L-929 cells.
Lewis JA
Prog Clin Biol Res; 1985; 202():325-32. PubMed ID: 2421311
[No Abstract] [Full Text] [Related]
16. Mechanism of the antiretroviral effect of dsRNA.
Müller WE; Ushijima H; Schröder HC
Prog Mol Subcell Biol; 1994; 14():66-88. PubMed ID: 7914807
[No Abstract] [Full Text] [Related]
17. Functional properties of proteins coded by three human alpha-interferon genes and a pseudogene.
Creasey AA; Vitt CR; Herst C; O'Rourke E; Doyle L; Innis MA; McCabe PC; McCormick F; Milley R; Lin LS
Cancer Res; 1988 Apr; 48(7):1763-70. PubMed ID: 2964896
[TBL] [Abstract][Full Text] [Related]
18. Conjunctival Kaposi's sarcoma treated with interferon alpha-2a.
Hummer J; Gass JD; Huang AJ
Am J Ophthalmol; 1993 Oct; 116(4):502-3. PubMed ID: 8213983
[No Abstract] [Full Text] [Related]
19. 2'-,5'-Oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis C.
Kim KI; Kim SR; Sasase N; Taniguchi M; Harada S; Kinoshita K; Kim SH; Akimoto Y; Shikata M; Kimura N; Izawa S; Ohtani A; Nakao K; Motojima M; Kinoshita M; Hirai M; Ohzu M; Hirooka T; Nabeshima S; Ishii F; Tanaka K; Hotta H
J Clin Pharm Ther; 2006 Oct; 31(5):441-6. PubMed ID: 16958821
[TBL] [Abstract][Full Text] [Related]
20. High levels of 2',5'-oligoadenylate synthetase and 2',5'-oligoadenylate-dependent endonuclease in human trophoblast.
Zhang GY; Beltchev B; Fournier A; Zhang YH; Malassiné A; Bisbal C; Ehresmann B; Ehresmann C; Darlix JL; Thang MN
AIDS Res Hum Retroviruses; 1993 Feb; 9(2):189-96. PubMed ID: 8457385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]